What is the appropriate ICD‑10 code for a screening mammogram and for a supplemental breast ultrasound performed for dense breast tissue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Codes for Screening Mammogram and Supplemental Breast Ultrasound

For a screening mammogram, use Z12.31 (Encounter for screening mammogram for malignant neoplasm of breast), and for supplemental breast ultrasound performed due to dense breast tissue, use Z12.39 (Encounter for other screening for malignant neoplasm of breast).

Screening Mammogram Coding

The primary ICD-10 code for routine screening mammography is:

  • Z12.31 - Encounter for screening mammogram for malignant neoplasm of breast

This code applies to asymptomatic women undergoing routine breast cancer screening, which remains the cornerstone of early detection with proven 30-40% mortality reduction 1.

Supplemental Breast Ultrasound Coding

For supplemental breast ultrasound performed specifically because of dense breast tissue, the appropriate code is:

  • Z12.39 - Encounter for other screening for malignant neoplasm of breast

Key Context for Supplemental Imaging

The FDA now mandates that all mammography facilities notify patients about breast density and inform them that supplemental imaging may be beneficial 1. Approximately half of screening-aged women have dense breasts (heterogeneously or extremely dense), which both increases cancer risk 4-6 fold and reduces mammography sensitivity by 30-48% 1.

Additional Coding Considerations

When documenting breast density, you may also want to reference the BI-RADS density category in clinical documentation:

  • BI-RADS A: Almost entirely fatty
  • BI-RADS B: Scattered fibroglandular elements
  • BI-RADS C: Heterogeneously dense
  • BI-RADS D: Extremely dense

For insurance authorization purposes, supplemental ultrasound is increasingly covered when performed for dense breast tissue (BI-RADS C or D categories), particularly as state-level insurance coverage laws expand 2.

Clinical Pitfalls to Avoid

  • Do not use diagnostic codes (such as R92.2 for inconclusive mammogram findings) when the ultrasound is purely for supplemental screening in dense breasts
  • Ensure proper documentation of breast density category in the mammogram report to support medical necessity for supplemental imaging
  • Be aware that coding practices may vary slightly by payer, so verify specific requirements with individual insurance carriers when prior authorization is needed

The evidence shows that supplemental ultrasound in women with dense breasts increases cancer detection by 3.0-3.5 additional cancers per 1,000 women screened 1, 3, though it does increase recall rates and false positives.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.